Sponsors

Company Profile

EraGen Biosciences Inc.

Molecular Diagnostics
in vitro Diagnostics
Genomics

918 Deming Way, Ste 201
Madison, WI 53717-1944
USA
www.eragen.com 		Incorporated in 1999
42 Employees 		Privately Held

This Year's Highlights

  • License and Development Agreement with Bayer HealthCare for MultiCode-PLx Cystic Fibrosis test in 2005
  • License Agreement with Promega Corporation for MultiCode-RTx System for marketing into the lifesciences market in 2004. Promega launched PLEXOR based on EraGen technology in 2006.
  • First-to-market Neisseria gonorhoea confirmatory test co-developed with AmeriPath for the clinical laboratory 2005

Anticipated Highlights

  • ISO 13485 Certification
  • Launch products(RUO,ASR and 510K)into the clinical diagnostics market
  • Expanded clinical laboratory partnerships

Corporate Mission

EraGen Biosciences, Inc. ("EraGen" or "the Company") designs, develops, manufactures and markets essential molecular diagnostic testing products. EraGen products include the next generation of automated genetic testing for early, accurate diagnosis of critical disease states including infectious diseases, genetic-based conditions and cancer. In addition, the Company?s innovative diagnostics serve emerging markets for personalized medicine and rapid biothreat response needs.